Who Paid My Doc
A22-203
Research payments
$2,045,959
Through program year 2025, $2,045,959 in research payments was reported against A22-203, across 173 payments, paid by PharmaEssentia USA Corporation.
- Paid by
- PharmaEssentia USA Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,691,827 | 143 |
| 2023 | Research | $354,133 | 30 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Swati Goel Bronx, NY Named on 32 payments
- Abdulraheem Yacoub Westwood, KS Named on 18 payments
- Rupali Bhave Winston Salem, NC Named on 14 payments
- John Mascarenhas New York, NY Named on 14 payments
- Stephen Oh Saint Louis, MO Named on 14 payments
- Tsewang Tashi Salt Lake City, UT Named on 14 payments
- Victor Priego Germantown, MD Named on 8 payments
- Lucia Masarova Houston, TX Named on 7 payments
- Brandi Reeves Chapel Hill, NC Named on 7 payments
- Hayman Salib Phillipsburg, NJ Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.